Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation-Reference-Cited by-同舟云学术

Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation

Published:2017-02-22 Issue:4 Volume:31 Page:e12899
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Ensor Christopher R.¹²^ORCID,Rihtarchik Lindsey C.³,Morrell Matthew R.²,Hayanga J. W. Awori⁴,Lichvar Alicia B.⁵,Pilewski Joseph M.²,Wisniewski Stephen⁶,Johnson Bruce A.²,D'Cunha Jonathan⁴,Zeevi Adriana⁷,McDyer John F.²

Affiliation:

1. Department of Pharmacy and Therapeutics; University of Pittsburgh School of Pharmacy; Pittsburgh PA USA

2. Division of Pulmonary, Allergy, and Critical Care Medicine; University of Pittsburgh School of Medicine; Pittsburgh PA USA

3. The Ohio State University Wexner Medical Center; Columbus OH USA

4. Department of Cardiothoracic Surgery; University of Pittsburgh School of Medicine; Pittsburgh PA USA

5. Department of Surgery; University of Cincinnati School of Medicine; Cincinnati OH USA

6. Graduate School of Public Health; University of Pittsburgh; Pittsburgh PA USA

7. Department of Pathology; University of Pittsburgh School of Medicine; Pittsburgh PA USA

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.12899/fullpdf

Reference21 articles.

1. The registry of the International Society of Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012;Christie;J Heart Lung Transplant,2012

2. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria;Estenne;J Heart Lung Transplant,2001

3. Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study;Jaksch;Am J Transplant,2014

4. A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation;Snell;Am J Transplant,2014

5. Evaluation of alemtuzumab versus basiliximab induction: a retrospective cohort study in lung transplant recipients;Whited;Transplantation,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies in Solid Organ Transplantation;Pharmaceutical Biotechnology;2024

2. Acute Rejection of the Lung Allograft: Phenotypes and Management;OBM Transplantation;2023-11-21

3. Lung Transplant Rejection;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

4. Incidence of Acute Cellular Rejection After Granulocyte Colony-Stimulating Factor in Lung Transplant Recipients;Journal of Pharmacy Practice;2023-06-21

5. Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction;Pharmacological Reviews;2023-06-09